ALIGN TECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 301.3 USD | +0.40% |
|
-7.25% | +9.98% |
| Apr. 18 | Stifel Nicolaus Adjusts Align Technology Price Target to $400 From $350 | MT |
| Apr. 15 | UBS Raises Align Technology Price Target to $320 From $280, Maintains Neutral Rating | MT |
Financials (USD)
| Sales 2024 * | 4.05B | Sales 2025 * | 4.46B | Capitalization | 22.59B |
|---|---|---|---|---|---|
| Net income 2024 * | 541M | Net income 2025 * | 624M | EV / Sales 2024 * | 5.24 x |
| Net cash position 2024 * | 1.36B | Net cash position 2025 * | 1.54B | EV / Sales 2025 * | 4.72 x |
| P/E ratio 2024 * |
41.9
x | P/E ratio 2025 * |
35.9
x | Employees | 21,610 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.46% |
More Fundamentals
* Assessed data
More news
Latest transcript on Align Technology, Inc.
More recommendations
More press releases
More news
| 1 day | +0.40% | ||
| 1 week | -7.25% | ||
| Current month | -8.11% | ||
| 1 month | -4.68% | ||
| 3 months | +13.92% | ||
| 6 months | +10.62% | ||
| Current year | +9.98% |
1 week
296.90
319.81
1 month
296.90335.40
Current year
250.28335.40
1 year
176.34413.20
3 years
172.05737.45
5 years
127.88737.45
10 years
43.27737.45
| Managers | Title | Age | Since |
|---|---|---|---|
Joseph Hogan
CEO | Chief Executive Officer | 65 | 15-05-31 |
John Morici
DFI | Director of Finance/CFO | 57 | 16-11-09 |
Zelko Relic
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
George Morrow
BRD | Director/Board Member | 72 | 06-01-31 |
Joseph Hogan
CEO | Chief Executive Officer | 65 | 15-05-31 |
Kevin Conroy
BRD | Director/Board Member | 58 | Dec. 04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.49% | 16 M€ | -8.26% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 301.3 | +0.40% | 417,020 |
| 24-04-17 | 300.1 | -1.63% | 574,960 |
| 24-04-16 | 305.1 | +0.12% | 502,777 |
| 24-04-15 | 304.7 | -3.25% | 549,893 |
| 24-04-12 | 315 | -3.06% | 631,737 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows:
- clear aligners (82.8%): sold under the brand name Invisalign;
- intra-oral scanners (17.2%): iTero. The group also offers scanner services.
Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
2024-04-24
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
300.1
USD
Average target price
321
USD
Spread / Average Target
+6.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.98% | 22.59B | |
| -4.36% | 184B | |
| -3.87% | 105B | |
| -4.38% | 67.09B | |
| +8.23% | 51.61B | |
| +15.54% | 47.55B | |
| +0.60% | 39.95B | |
| +7.16% | 27.62B | |
| -12.48% | 25.74B | |
| -1.68% | 25.62B |
- Stock Market
- Equities
- ALGN Stock
